3rd Quarter - Report

IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions
LINDSEY TRISCHLER —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2369 (118th)

Health Issues HCR

No bill #: Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Workforce shortages National Biodefense Science Board Recommendations

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Health, Education, Labor and Pensions
LINDSEY TRISCHLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S.2140: Patent Eligibility Restoration Act of 2023

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor and Pensions
LINDSEY TRISCHLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2140 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.